Volume 9, Number 8, August 2003

NmcA Carbapenem-hydrolyzing Enzyme in Enterobacter cloacae in North America

Sudha Pottumarthy,* Ellen Smith Moland,† Stefan Juretschko,* Susan R. Swanzy,* Kenneth S. Thomson,† and Thomas R. Fritsche*
*University of Washington School of Medicine, Seattle, Washington, USA: and †Creighton University Medical Center, Omaha, Nebraska, USA

Figure 2. Effect of addition of clavulanic acid (10 μL of 1,000 mg/mL) to the zones of inhibition of the three carbapenem disks. Top row (left to right): imipenem, meropenem, and ertapenem disks without clavulanic acid. Bottom row (left to right): imipenem, meropenem, and ertapenem disks with clavulanic acid.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed July 17, 2003

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention